Soft Tissue/Laparoscopic Surgical Robot Market Report – Research, Industry Analysis Reports and Market Demands

Global Soft Tissue/Laparoscopic Surgical Robot Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Multi-port Surgical Robot
- 1.3.3 Single-port Surgical Robot
1.4 Market Analysis by Operation Mode
- 1.4.1 Overview: Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Operation Mode: 2021 Versus 2025 Versus 2032
- 1.4.2 Master-Slave Teleoperation Type
- 1.4.3 Master-Slave Collaborative Type
- 1.4.4 Handheld Auxiliary Type
- 1.4.5 Semi-Autonomous Type
1.5 Market Analysis by Number of Robotic Arms
- 1.5.1 Overview: Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Number of Robotic Arms: 2021 Versus 2025 Versus 2032
- 1.5.2 Single Arm
- 1.5.3 Dual Arm
- 1.5.4 Triple Arm
- 1.5.5 Four Arms and Above
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Urology
- 1.6.3 Gynecology
- 1.6.4 General Surgery
- 1.6.5 Colorectal Surgery
- 1.6.6 Thoracic Surgery
- 1.6.7 Hepatobiliary-pancreatic Surgery
- 1.6.8 Gastrointestinal Surgery
- 1.6.9 Other
1.7 Global Soft Tissue/Laparoscopic Surgical Robot Market Size & Forecast
- 1.7.1 Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Soft Tissue/Laparoscopic Surgical Robot Sales Quantity (2021-2032)
- 1.7.3 Global Soft Tissue/Laparoscopic Surgical Robot Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Soft Tissue/Laparoscopic Surgical Robot by Manufacturer

3.1 Global Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Manufacturer (2021-2026)
3.2 Global Soft Tissue/Laparoscopic Surgical Robot Revenue by Manufacturer (2021-2026)
3.3 Global Soft Tissue/Laparoscopic Surgical Robot Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Soft Tissue/Laparoscopic Surgical Robot by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Soft Tissue/Laparoscopic Surgical Robot Manufacturer Market Share in 2025
- 3.4.3 Top 6 Soft Tissue/Laparoscopic Surgical Robot Manufacturer Market Share in 2025
3.5 Soft Tissue/Laparoscopic Surgical Robot Market: Overall Company Footprint Analysis
- 3.5.1 Soft Tissue/Laparoscopic Surgical Robot Market: Region Footprint
- 3.5.2 Soft Tissue/Laparoscopic Surgical Robot Market: Company Product Type Footprint
- 3.5.3 Soft Tissue/Laparoscopic Surgical Robot Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Soft Tissue/Laparoscopic Surgical Robot Market Size by Region
- 4.1.1 Global Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Region (2021-2032)
- 4.1.2 Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Region (2021-2032)
- 4.1.3 Global Soft Tissue/Laparoscopic Surgical Robot Average Price by Region (2021-2032)
4.2 North America Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021-2032)
4.3 Europe Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021-2032)
4.4 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021-2032)
4.5 South America Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021-2032)
4.6 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
5.2 Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Type (2021-2032)
5.3 Global Soft Tissue/Laparoscopic Surgical Robot Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
6.2 Global Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Application (2021-2032)
6.3 Global Soft Tissue/Laparoscopic Surgical Robot Average Price by Application (2021-2032)

7 North America

7.1 North America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
7.2 North America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
7.3 North America Soft Tissue/Laparoscopic Surgical Robot Market Size by Country
- 7.3.1 North America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Country (2021-2032)
- 7.3.2 North America Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
8.2 Europe Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
8.3 Europe Soft Tissue/Laparoscopic Surgical Robot Market Size by Country
- 8.3.1 Europe Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Market Size by Region
- 9.3.1 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
10.2 South America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
10.3 South America Soft Tissue/Laparoscopic Surgical Robot Market Size by Country
- 10.3.1 South America Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Country (2021-2032)
- 10.3.2 South America Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Market Size by Country
- 11.3.1 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Soft Tissue/Laparoscopic Surgical Robot Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Soft Tissue/Laparoscopic Surgical Robot Market Drivers
12.2 Soft Tissue/Laparoscopic Surgical Robot Market Restraints
12.3 Soft Tissue/Laparoscopic Surgical Robot Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Soft Tissue/Laparoscopic Surgical Robot and Key Manufacturers
13.2 Manufacturing Costs Percentage of Soft Tissue/Laparoscopic Surgical Robot
13.3 Soft Tissue/Laparoscopic Surgical Robot Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Soft Tissue/Laparoscopic Surgical Robot Typical Distributors
14.3 Soft Tissue/Laparoscopic Surgical Robot Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Soft Tissue/Laparoscopic Surgical Robot market size was valued at US$ 11877 million in 2025 and is forecast to a readjusted size of US$ 28713 million by 2032 with a CAGR of 13.3% during review period.
Soft tissue and laparoscopic surgical robots are robotic-assisted surgical systems designed for minimally invasive procedures in abdominal, pelvic, thoracic, natural-orifice, and other soft tissue surgical fields. A typical system consists of a surgeon console, patient-side robotic arms, a three-dimensional high-definition endoscopic vision system, wristed surgical instruments, energy-device interfaces, image processing software, motion-control algorithms, safety redundancy modules, training and data platforms, and procedure-specific instruments and consumables. These systems translate the surgeon’s hand movements into precise intracorporeal instrument motion through master-slave control, tremor filtration, motion scaling, magnified 3D visualization, and multi-degree-of-freedom instrument articulation. They support surgical tasks such as cutting, dissection, suturing, ligation, grasping, traction, hemostasis, and reconstruction. The scope of this study mainly covers multi-port laparoscopic surgical robots, single-port laparoscopic robots, modular laparoscopic robotic systems, miniaturized surgical robots, and multi-specialty soft tissue robotic platforms. Key clinical specialties include urology, gynecology, general surgery, colorectal surgery, thoracic surgery, hepatobiliary-pancreatic surgery, gastrointestinal surgery, and selected head and neck procedures. Key evaluation metrics include system stability, robotic arm freedom, wristed instrumentation, visualization quality, latency, operating-room integration, instrument reuse, consumable cost, indication coverage, learning curve, telesurgery capability, regulatory approval, and hospital-level economics.
In 2025, the global production of soft tissue/laparoscopic surgical robots was 2,380 units, with an average price of US$4.85 million per unit and an average gross profit margin of 64.2%.
Based on our research, the soft tissue and laparoscopic surgical robot market is not merely a robotics concept market; it is a full ecosystem built around minimally invasive soft tissue surgery, combining systems, instruments, consumables, services, training, software, and clinical workflow integration. The category first scaled in urology and then expanded into gynecology, general surgery, colorectal surgery, thoracic surgery, hepatobiliary-pancreatic surgery, and other complex laparoscopic procedures. Compared with conventional laparoscopy, robotic systems provide three-dimensional visualization, wristed instruments, motion scaling, tremor filtration, and improved surgeon ergonomics. These features are particularly valuable in deep pelvic surgery, suturing-intensive procedures, reconstructive surgery, and multi-quadrant operations. Because the business model depends heavily on instruments, accessories, service contracts, and procedure volume, the revenue model should include systems, consumables, services, and directly related software rather than only capital equipment sales.
From a supply perspective, Intuitive Surgical remains the dominant global leader, supported by the da Vinci installed base, procedural volume, clinical evidence, surgeon familiarity, and a recurring instrument and service revenue model. However, the competitive structure is becoming more diverse. Medtronic Hugo emphasizes a modular arm-cart architecture, CMR Versius focuses on portability and access, Medicaroid hinotori represents Japan’s domestic robotic surgery platform, and Chinese companies such as MicroPort MedBot, Edge Medical, KangDuo, Surgerii, and Ronovo are expanding through domestic approvals, clinical adoption, telesurgery demonstrations, and multi-specialty product roadmaps. At the same time, platforms such as Virtual Incision MIRA, Moon Surgical Maestro, Distalmotion DEXTER, avatera, Revo-i, and Meril Mizzo Endo 4000 show that the market is no longer limited to one full-featured master-slave system architecture.
From a demand perspective, adoption is driven by the growth of complex minimally invasive procedures, patient preference for less invasive surgery, surgeon demand for precision and ergonomics, hospital competition in advanced surgical capabilities, and the recurring economics of high-volume robotic programs. North America remains the largest market due to procedure volume and reimbursement structure. Europe and Japan are growing under more controlled hospital budgeting and regulatory pathways. China is accelerating through domestic substitution, tertiary-hospital expansion, local manufacturing, and lower system acquisition cost. India, Korea, and selected Middle Eastern markets are becoming more relevant as local manufacturers and hospital systems begin investing in robotic-assisted surgery. Future growth will depend not only on system placements but also on utilization, indication expansion, instrument cost reduction, training efficiency, and hospital-level return on investment.
From a technology perspective, the industry is evolving beyond conventional multi-port systems. Multi-port robots remain the core architecture for broad soft tissue use, but single-port systems are gaining relevance in urology, gynecology, and natural-orifice approaches. Modular systems allow hospitals to configure arm carts based on procedure type and operating-room constraints. Miniaturized systems and robotic assistants aim to reduce space, setup, and cost barriers. Johnson & Johnson’s OTTAVA, Virtual Incision’s MIRA, and Moon Surgical’s Maestro illustrate a broader shift toward differentiated architectures rather than direct da Vinci imitation. In the medium term, AI-assisted workflow, image guidance, data analytics, remote surgery, haptic feedback, open instrument ecosystems, and lower-cost disposable strategies will become important areas of competition.
From a risk perspective, the market still faces high capital cost, clinical evidence requirements, regulatory scrutiny, consumable economics, and training burdens. Hospitals need sufficient procedure volume to justify system purchase and service contracts. New entrants may compete on price or modularity, but they must still prove safety, clinical value, reliability, and service capability. Device recalls and software-related safety concerns show that motion control, redundancy, cybersecurity, and human-machine interaction are critical. Over time, the market is likely to become more layered: premium platforms will dominate complex high-volume procedures, cost-efficient modular systems will expand access in mid-tier hospitals, and lightweight robotic assistants may supplement standard laparoscopy in selected procedures. The long-term winners will be companies that combine clinical evidence, installed base, consumable economics, regulatory execution, surgeon training, and reliable after-sales service.
This report is a detailed and comprehensive analysis for global Soft Tissue/Laparoscopic Surgical Robot market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Soft Tissue/Laparoscopic Surgical Robot market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Soft Tissue/Laparoscopic Surgical Robot market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Soft Tissue/Laparoscopic Surgical Robot market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Soft Tissue/Laparoscopic Surgical Robot market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Soft Tissue/Laparoscopic Surgical Robot
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Soft Tissue/Laparoscopic Surgical Robot market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intuitive Surgical, Medtronic, CMR Surgical, Johnson & Johnson, Asensus Surgical, Medicaroid, MicroPort MedBot, Edge Medical, KangDuo Surgical Robot, Surgerii Robotics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Soft Tissue/Laparoscopic Surgical Robot market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Multi-port Surgical Robot
Single-port Surgical Robot
Market segment by Operation Mode
Master-Slave Teleoperation Type
Master-Slave Collaborative Type
Handheld Auxiliary Type
Semi-Autonomous Type
Market segment by Number of Robotic Arms
Single Arm
Dual Arm
Triple Arm
Four Arms and Above
Market segment by Application
Urology
Gynecology
General Surgery
Colorectal Surgery
Thoracic Surgery
Hepatobiliary-pancreatic Surgery
Gastrointestinal Surgery
Other
Major players covered
Intuitive Surgical
Medtronic
CMR Surgical
Johnson & Johnson
Asensus Surgical
Medicaroid
MicroPort MedBot
Edge Medical
KangDuo Surgical Robot
Surgerii Robotics
Ronovo Surgical
WEGO Medical
Revo Surgical
avateramedical
Distalmotion
Virtual Incision
Moon Surgical
Meril Life Sciences
Titan Medical
Vicarious Surgical
EndoQuest Robotics
Momentis Surgical
SS Innovations International
Beijing Baihui Weikang Technology
Beijing TINAVI Medical Technologies
Shanghai United Imaging Intelligence
Shenzhen Reetoo Biotechnology
Beijing Changmugu Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Soft Tissue/Laparoscopic Surgical Robot product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Soft Tissue/Laparoscopic Surgical Robot, with price, sales quantity, revenue, and global market share of Soft Tissue/Laparoscopic Surgical Robot from 2021 to 2026.
Chapter 3, the Soft Tissue/Laparoscopic Surgical Robot competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Soft Tissue/Laparoscopic Surgical Robot breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Soft Tissue/Laparoscopic Surgical Robot market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Soft Tissue/Laparoscopic Surgical Robot.
Chapter 14 and 15, to describe Soft Tissue/Laparoscopic Surgical Robot sales channel, distributors, customers, research findings and conclusion.

Buy now